Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oncolytic virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40-ligand

Oncolytic virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40-ligand

US Patent 12239666 · Granted Mar 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Variant survivin vaccine for treatment of myeloma2025
Methods of CD40 and toll like receptor immune activation2024
Replication-enhanced oncolytic adenoviruses2024
Replication-enhanced oncolytic adenoviruses2024
Methods of CD40 activation and immune checkpoint blockade2023
Armed oncolytic viruses2022
Variant survivin vaccine for treatment of myeloma2021
Combination immunotherapy for treating cancer2021
GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy2021
Conjugates for immunotherapy2019
Double mutant survivin vaccine2019
Gene signature for the prediction of NF-kappaB activity2015